VBLT Annual EBIT
-$32.22 M
-$2.34 M-7.84%
31 December 2022
Summary:
As of February 5, 2025, VBLT annual earnings before interest & taxes is -$32.22 million, with the most recent change of -$2.34 million (-7.84%) on December 31, 2022. During the last 3 years, it has fallen by -$13.01 million (-67.70%).VBLT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBLT Quarterly EBIT
-$863.00 K
+$1.76 M+67.06%
30 June 2023
Summary:
As of February 5, 2025, VBLT quarterly earnings before interest & taxes is -$863.00 thousand, with the most recent change of +$1.76 million (+67.06%) on June 30, 2023. Over the past year, it has increased by +$8.55 million (+90.83%).VBLT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBLT TTM EBIT
-$15.88 M
+$8.55 M+34.99%
30 June 2023
Summary:
As of February 5, 2025, VBLT TTM earnings before interest & taxes is -$15.88 million, with the most recent change of +$8.55 million (+34.99%) on June 30, 2023. Over the past year, it has increased by +$19.54 million (+55.18%).VBLT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBLT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | +90.8% | +55.2% |
| 3 y3 years | -67.7% | +85.2% | +26.7% |
| 5 y5 years | -218.7% | +78.7% | +17.4% |
VBLT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +223.6% | -113.7% | +324.2% |
Vascular Biogenics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$863.00 K(-67.1%) | -$15.88 M(-35.0%) |
| Mar 2023 | - | -$2.62 M(-19.6%) | -$24.42 M(-24.2%) |
| Dec 2022 | -$32.22 M(+7.8%) | -$3.26 M(-64.3%) | -$32.22 M(-15.3%) |
| Sept 2022 | - | -$9.13 M(-2.9%) | -$38.06 M(+7.5%) |
| June 2022 | - | -$9.41 M(-9.7%) | -$35.42 M(+4.1%) |
| Mar 2022 | - | -$10.42 M(+14.5%) | -$34.03 M(+13.9%) |
| Dec 2021 | -$29.88 M(+23.9%) | -$9.10 M(+40.1%) | -$29.88 M(+6.8%) |
| Sept 2021 | - | -$6.49 M(-19.0%) | -$27.98 M(+2.7%) |
| June 2021 | - | -$8.02 M(+28.1%) | -$27.25 M(+8.8%) |
| Mar 2021 | - | -$6.26 M(-13.0%) | -$25.05 M(+3.8%) |
| Dec 2020 | -$24.12 M(+25.5%) | -$7.20 M(+24.8%) | -$24.12 M(+6.4%) |
| Sept 2020 | - | -$5.77 M(-0.9%) | -$22.67 M(+4.7%) |
| June 2020 | - | -$5.82 M(+9.1%) | -$21.66 M(+6.0%) |
| Mar 2020 | - | -$5.34 M(-7.2%) | -$20.44 M(+6.4%) |
| Dec 2019 | -$19.21 M(-5.5%) | -$5.75 M(+20.9%) | -$19.21 M(+10.7%) |
| Sept 2019 | - | -$4.75 M(+3.4%) | -$17.36 M(-2.8%) |
| June 2019 | - | -$4.60 M(+12.0%) | -$17.85 M(+3.2%) |
| Mar 2019 | - | -$4.11 M(+5.5%) | -$17.30 M(-15.0%) |
| Dec 2018 | -$20.34 M | -$3.89 M(-25.8%) | -$20.34 M(+100.3%) |
| Sept 2018 | - | -$5.25 M(+29.8%) | -$10.15 M(-11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$4.04 M(-43.4%) | -$11.41 M(-6.7%) |
| Mar 2018 | - | -$7.15 M(-213.6%) | -$12.23 M(+21.0%) |
| Dec 2017 | -$10.11 M(-37.9%) | $6.29 M(-196.7%) | -$10.11 M(-53.0%) |
| Sept 2017 | - | -$6.50 M(+33.6%) | -$21.49 M(+18.2%) |
| June 2017 | - | -$4.87 M(-3.2%) | -$18.18 M(+9.7%) |
| Mar 2017 | - | -$5.03 M(-1.1%) | -$16.58 M(+1.0%) |
| Dec 2016 | -$16.27 M(+9.4%) | -$5.09 M(+59.4%) | -$16.41 M(+13.1%) |
| Sept 2016 | - | -$3.19 M(-2.4%) | -$14.51 M(-14.9%) |
| June 2016 | - | -$3.27 M(-32.8%) | -$17.05 M(+0.9%) |
| Mar 2016 | - | -$4.87 M(+52.8%) | -$16.91 M(+13.8%) |
| Dec 2015 | -$14.87 M(+0.6%) | -$3.18 M(-44.5%) | -$14.86 M(-11.0%) |
| Sept 2015 | - | -$5.74 M(+83.6%) | -$16.70 M(+16.3%) |
| June 2015 | - | -$3.12 M(+11.0%) | -$14.35 M(-2.2%) |
| Mar 2015 | - | -$2.81 M(-44.0%) | -$14.67 M(-0.7%) |
| Dec 2014 | -$14.78 M(-7.4%) | -$5.02 M(+48.2%) | -$14.78 M(+1.5%) |
| Sept 2014 | - | -$3.39 M(-1.5%) | -$14.56 M(-2.4%) |
| June 2014 | - | -$3.44 M(+17.7%) | -$14.91 M(+30.0%) |
| Mar 2014 | - | -$2.92 M(-39.1%) | -$11.47 M(+34.2%) |
| Dec 2013 | -$15.96 M(+28.0%) | -$4.80 M(+28.4%) | -$8.54 M(+128.4%) |
| Sept 2013 | - | -$3.74 M | -$3.74 M |
| Dec 2012 | -$12.47 M | - | - |
FAQ
- What is Vascular Biogenics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vascular Biogenics?
- What is Vascular Biogenics annual EBIT year-on-year change?
- What is Vascular Biogenics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vascular Biogenics?
- What is Vascular Biogenics quarterly EBIT year-on-year change?
- What is Vascular Biogenics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vascular Biogenics?
- What is Vascular Biogenics TTM EBIT year-on-year change?
What is Vascular Biogenics annual earnings before interest & taxes?
The current annual EBIT of VBLT is -$32.22 M
What is the all time high annual EBIT for Vascular Biogenics?
Vascular Biogenics all-time high annual earnings before interest & taxes is -$9.96 M
What is Vascular Biogenics annual EBIT year-on-year change?
Over the past year, VBLT annual earnings before interest & taxes has changed by -$2.34 M (-7.84%)
What is Vascular Biogenics quarterly earnings before interest & taxes?
The current quarterly EBIT of VBLT is -$863.00 K
What is the all time high quarterly EBIT for Vascular Biogenics?
Vascular Biogenics all-time high quarterly earnings before interest & taxes is $6.29 M
What is Vascular Biogenics quarterly EBIT year-on-year change?
Over the past year, VBLT quarterly earnings before interest & taxes has changed by +$8.55 M (+90.83%)
What is Vascular Biogenics TTM earnings before interest & taxes?
The current TTM EBIT of VBLT is -$15.88 M
What is the all time high TTM EBIT for Vascular Biogenics?
Vascular Biogenics all-time high TTM earnings before interest & taxes is -$3.74 M
What is Vascular Biogenics TTM EBIT year-on-year change?
Over the past year, VBLT TTM earnings before interest & taxes has changed by +$19.54 M (+55.18%)